These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33854066)

  • 1. Microbiota-based markers predictive of development of Clostridioides difficile infection.
    Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S;
    Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.
    van Werkhoven CH; Ducher A; Berkell M; Mysara M; Lammens C; Torre-Cisneros J; Rodríguez-Baño J; Herghea D; Cornely OA; Biehl LM; Bernard L; Dominguez-Luzon MA; Maraki S; Barraud O; Nica M; Jazmati N; Sablier-Gallis F; de Gunzburg J; Mentré F; Malhotra-Kumar S; Bonten MJM; Vehreschild MJGT;
    Nat Commun; 2021 Apr; 12(1):2240. PubMed ID: 33854064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 6. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
    Hawes AM; Desai A; Patel PK
    Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
    Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
    Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
    Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
    Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
    Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
    Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
    Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
    mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
    Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
    mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the diagnosis and treatment of Clostridium difficile infections.
    Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
    Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ridinilazole: a novel therapy for Clostridium difficile infection.
    Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
    Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.
    Pakpour S; Bhanvadia A; Zhu R; Amarnani A; Gibbons SM; Gurry T; Alm EJ; Martello LA
    Microbiome; 2017 Nov; 5(1):148. PubMed ID: 29132405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection.
    Vakili B; Fateh A; Asadzadeh Aghdaei H; Sotoodehnejadnematalahi F; Siadat SD
    Curr Microbiol; 2020 Aug; 77(8):1673-1680. PubMed ID: 32296918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
    Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
    Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
    Mehta SR; Yen EF
    Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection.
    Bosnjak M; Karpe AV; Van TTH; Kotsanas D; Jenkin GA; Costello SP; Johanesen P; Moore RJ; Beale DJ; Srikhanta YN; Palombo EA; Larcombe S; Lyras D
    Nat Commun; 2023 Nov; 14(1):7737. PubMed ID: 38007555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.